133 related articles for article (PubMed ID: 9805229)
1. Interleukin-12 overcomes paclitaxel-mediated suppression of T-cell proliferation.
Mullins DW; Koci MD; Burger CJ; Elgert KD
Immunopharmacol Immunotoxicol; 1998 Nov; 20(4):473-92. PubMed ID: 9805229
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel enhances macrophage IL-12 production in tumor-bearing hosts through nitric oxide.
Mullins DW; Burger CJ; Elgert KD
J Immunol; 1999 Jun; 162(11):6811-8. PubMed ID: 10352302
[TBL] [Abstract][Full Text] [Related]
3. Post-chemotherapeutic administration of interleukin-12 retards tumor growth and enhances immune cell function: combination therapy using paclitaxel and IL-12.
Pressley JS; Elgert KD
Cancer Invest; 2006; 24(4):351-9. PubMed ID: 16777686
[TBL] [Abstract][Full Text] [Related]
4. Taxol-mediated changes in fibrosarcoma-induced immune cell function: modulation of antitumor activities.
Mullins DW; Walker TM; Burger CJ; Elgert KD
Cancer Immunol Immunother; 1997 Oct; 45(1):20-8. PubMed ID: 9353423
[TBL] [Abstract][Full Text] [Related]
5. Increased sensitivity of tumor-bearing host macrophages to interleukin-10: a counter-balancing action to macrophage-mediated suppression.
Alleva DG; Burger CJ; Elgert KD
Oncol Res; 1994; 6(4-5):219-28. PubMed ID: 7841545
[TBL] [Abstract][Full Text] [Related]
6. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
[TBL] [Abstract][Full Text] [Related]
7. Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.
Alleva DG; Burger CJ; Elgert KD
J Immunol; 1994 Aug; 153(4):1674-86. PubMed ID: 8046239
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T cells: modulation by interleukin-4 and interleukin-12.
Jung T; Wijdenes J; Neumann C; de Vries JE; Yssel H
Eur J Immunol; 1996 Mar; 26(3):571-7. PubMed ID: 8605923
[TBL] [Abstract][Full Text] [Related]
9. LPS-stimulated SJL macrophages produce IL-12 and IL-18 that inhibit IgE production in vitro by induction of IFN-gamma production from CD3intIL-2R beta+ T cells.
Yoshimoto T; Nagai N; Ohkusu K; Ueda H; Okamura H; Nakanishi K
J Immunol; 1998 Aug; 161(3):1483-92. PubMed ID: 9686615
[TBL] [Abstract][Full Text] [Related]
10. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell-derived TGF-beta and IL-10 dysregulate paclitaxel-induced macrophage activation.
Mullins DW; Martins RS; Burger CJ; Elgert KD
J Leukoc Biol; 2001 Jan; 69(1):129-37. PubMed ID: 11200057
[TBL] [Abstract][Full Text] [Related]
12. Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma.
Komita H; Homma S; Saotome H; Zeniya M; Ohno T; Toda G
J Hepatol; 2006 Nov; 45(5):662-72. PubMed ID: 16935390
[TBL] [Abstract][Full Text] [Related]
13. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection.
Abrahamsohn IA; Coffman RL
J Immunol; 1995 Oct; 155(8):3955-63. PubMed ID: 7561103
[TBL] [Abstract][Full Text] [Related]
14. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
15. Tumor growth modulates macrophage nitric oxide production following paclitaxel administration.
Mullins DW; Burger CJ; Elgert KD
Int J Immunopharmacol; 1998 Oct; 20(10):537-51. PubMed ID: 9839658
[TBL] [Abstract][Full Text] [Related]
16. Differential effect of IL-10 on dendritic cell-induced T cell proliferation and IFN-gamma production.
Macatonia SE; Doherty TM; Knight SC; O'Garra A
J Immunol; 1993 May; 150(9):3755-65. PubMed ID: 8097224
[TBL] [Abstract][Full Text] [Related]
17. Periplocoside E, an effective compound from Periploca sepium Bge, inhibited T cell activation in vitro and in vivo.
Zhu YN; Zhao WM; Yang YF; Liu QF; Zhou Y; Tian J; Ni J; Fu YF; Zhong XG; Tang W; Zhou R; He PL; Li XY; Zuo JP
J Pharmacol Exp Ther; 2006 Feb; 316(2):662-9. PubMed ID: 16204471
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of IL-12, not a shift from a T helper-1 to a T helper-2 phenotype, is responsible for impaired IFN-gamma production in mammary tumor-bearing mice.
Handel-Fernandez ME; Cheng X; Herbert LM; Lopez DM
J Immunol; 1997 Jan; 158(1):280-6. PubMed ID: 8977200
[TBL] [Abstract][Full Text] [Related]
19. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
[TBL] [Abstract][Full Text] [Related]
20. Suppressive effect of a novel water-soluble artemisinin derivative SM905 on T cell activation and proliferation in vitro and in vivo.
Wang JX; Tang W; Yang ZS; Wan J; Shi LP; Zhang Y; Zhou R; Ni J; Hou LF; Zhou Y; He PL; Yang YF; Li Y; Zuo JP
Eur J Pharmacol; 2007 Jun; 564(1-3):211-8. PubMed ID: 17349993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
